EP1525052A1 - Particule d'echange ionique a exclusion de dimension - Google Patents

Particule d'echange ionique a exclusion de dimension

Info

Publication number
EP1525052A1
EP1525052A1 EP03771853A EP03771853A EP1525052A1 EP 1525052 A1 EP1525052 A1 EP 1525052A1 EP 03771853 A EP03771853 A EP 03771853A EP 03771853 A EP03771853 A EP 03771853A EP 1525052 A1 EP1525052 A1 EP 1525052A1
Authority
EP
European Patent Office
Prior art keywords
ion
exchange
core
poly
size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03771853A
Other languages
German (de)
English (en)
Inventor
Aldrich Lau
Michael Harrold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Applera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/414,179 external-priority patent/US20040018559A1/en
Priority claimed from US10/413,935 external-priority patent/US6833238B2/en
Application filed by Applera Corp filed Critical Applera Corp
Publication of EP1525052A1 publication Critical patent/EP1525052A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/018—Granulation; Incorporation of ion-exchangers in a matrix; Mixing with inert materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4005—Concentrating samples by transferring a selected component through a membrane
    • G01N2001/4016—Concentrating samples by transferring a selected component through a membrane being a selective membrane, e.g. dialysis or osmosis

Definitions

  • the present teachings relate to apparatuses and methods for filtering and/or purifying a sample by using ion-exchange techniques.
  • PCR polymerase chain reaction
  • sequencing reaction can present a number of challenges for subsequent, downstream processing. Impurities can cause artifacts in subsequent processing steps. Numerous purification steps to eliminate artifacts can be cumbersome and inefficient. Further, purification, such as by size-exclusion chromatography or ion-exchange chromatography, requires a respective well-formed resin bed, without cracks, bubbles, or channels, as well as correct sample-loading techniques. Resin beds used for purification, for example, by size-exclusion, can be ten times or more the volume of the sample in size, requiring much space and increasing the cost of purification.
  • ion-exchange resins often interact undesirably with target analytes as opposed to interacting with the ions the resins are supposed to remove. Further, purification using ion-exchange materials can require elution of the analyte using a high salt eluant, which can be undesirable for subsequent analysis and/or reactions. A need exists for a purification method that addresses these and other problems associated with conventional techniques of purification.
  • a size-exclusion ion-exchange (SEIE) particle can include a core and a shell, wherein the core comprises ion-exchange material, and the shell comprises size-exclusion material.
  • SEIE size-exclusion ion-exchange
  • a method of forming a size-exclusion ion- exchange particle can include providing an ion-exchange core, and micro-encapsulating the ion-exchange core with a size-exclusion material.
  • the core can be positioned in an emulsion comprising a polymerizable monomer, and the core can be micro-encapsulated by polymerizing the monomer to form a shell having pores capable of excluding material larger than a pre-determined size.
  • a method of purifying a sample is provided. The method can include providing such a sample, contacting the sample with one or more size-exclusion ion-exchange particles to form a purified sample, and removing/separating the purified sample from the size-exclusion ion-exchange particles.
  • FIG. 1 is a schematic diagram of an interaction of an anionic species with a size- exclusion ion-exchange particle, according to various embodiments
  • FIG. 2 is a schematic diagram of the core-shell structures of a size-exclusion ion- exchange core, having cutaways to show the surface of the core and the interior of the core.
  • Fig. 3 is a schematic diagram showing formation of a shell on an ion-exchange core by inverse emulsification and polymerization, according to various embodiments;
  • Fig. 4 is a diagram illustrating the formation of a size-exclusion ion-exchange particle, according to various embodiments;
  • Fig. 5 is a diagram illustrating a derivatization of an ion-exchange resin
  • FIG. 6 is a diagram illustrating the formation of a reactive polyanion
  • Fig. 7 is a schematic diagram of the formation of a size-exclusion ion-exchange particle, wherein one step is surface activation of the ion-exchange core, according to various embodiments;
  • FIG. 8 is a schematic diagram of two pathways for formation of a size-exclusion ion-exchange particle, wherein one common step is surface activation of the ion-exchange core, according to various embodiments;
  • Fig. 9 is a series of graphs of (a) data acquired from a raw sample including a mixture of a dye-labeled amplicon and a dye-labeled primer, and data acquired after incubation of the sample with a size-exclusion ion-exchange particle according to various embodiments for (b) two minutes, (c) five minutes, and (d) ten minutes, to remove the dye- labeled primer;
  • Figs. 10a and 10b demonstrate the results of sequencing a PCR product purified using size-exclusion ion-exchange particles, wherein Fig. 10a is data from sequencing a raw PCR product, and Fig. 10b is data from sequencing a PCR product as purified by contact with size-exclusion ion-exchange particles according to various embodiments;
  • Figs, lla-d demonstrate purification of a sequencing reaction by contact with size-exclusion ion-exchange particles in comparison with standard purification techniques, wherein Fig. 1 la is raw data of the unpurified sample, Fig. 1 lb is data from a sample purified with a CentriStep column, and Figs, lie and 1 Id are data from a sample purified by contact with size-exclusion ion-exchange particles, according to various embodiments;
  • Fig. 12 is a graph showing, for a population, the difference in size between an anion-exchange core and a resultant SEIE particle containing the anion-exchange core, according to various embodiments.
  • Fig. 13 is a graph showing, for a population, the difference in size between an anion-exchange core and a resultant SEIE particle containing the anion-exchange core, according to various embodiments.
  • size-exclusion ion-exchange (SEIE) particles having an ion-exchange core micro-encapsulated by a shell capable of size-exclusion are provided.
  • SEIE size-exclusion ion-exchange
  • micro-encapsulation refers to a process of encapsulation on the individual particle level.
  • a core of liquid, solid, and/or gas is micro-encapsulated with a shell to control access to the core.
  • micro-encapsulation can coat the entire exterior surface of the core (and optionally interior surfaces), or it can coat only a portion of the exterior surface of the core (and optionally interior surfaces).
  • micro- encapsulation of the core can be irreversible to permanently coat the core, or reversible to release the core upon dissolution of the coating.
  • micro-encapsulation can include encapsulation of an agglomerate of core material in a shell.
  • the aggregate can be fused, sintered, pressed, compressed, or otherwise formed together core materials.
  • the core material can be a single particle and not an aggregate.
  • core or “core material” can refer to a single particle or an aggregate of particles.
  • shell refers to coating any portion of the core exterior surface and/or interior surface. The dimensions and formation of the shell are described below.
  • the term "material” refers to any substance on a molecular level or in bulk.
  • a material can be a liquid and/or solid, e.g. an emulsion or a resin.
  • a "mixture" can refer to more than one SEIE particle used together in a packed column, a mixed-bed, a homogenous bed, a fluidized bed, a static column with continuous flow, or a batch mixture, for example.
  • the mixture can include size-exclusion cation-exchange particles and size-exclusion anion-exchange particles, size- exclusion cation-exchange particles and anion-exchange particles, size-exclusion anion- exchange particles and cation-exchange particles, SEIE particles and inerts, or a combination thereof.
  • the mixture can include any physical configuration known in the art of separations, and any chemical mixture known in the art of ion exchange.
  • Small molecules such as, for example, inorganic ions and nucleotides, can penetrate or permeate through the size-exclusion shell and can be retained by or ion- exchanged with the ion-exchange core.
  • the shell can prevent larger ions, such as, for example, DNA fragments, from penetrating or permeating through the shell and reacting with the ion-exchange core.
  • SEIE particles can have many uses such as, for example, in the purification of biomolecules. Applications can include, for example, purification of polymerase chain reaction (PCR) products, purification of DNA sequencing reaction mixtures, and purification of RNA. SEIE particles can also be used for purification and/or separation of, for example, oligonucleotides, ligase chain reaction products, proteins, antibody binding reaction products, oligonucleotide ligation assay products, hybridization products, and antibodies. SEIE particles can also be used for desalting of biological products or reaction mixtures.
  • PCR polymerase chain reaction
  • SEIE particles can also be used for purification and/or separation of, for example, oligonucleotides, ligase chain reaction products, proteins, antibody binding reaction products, oligonucleotide ligation assay products, hybridization products, and antibodies. SEIE particles can also be used for desalting of biological products or reaction mixtures.
  • SEIE particle combine the benefits of size- exclusion chromatography (SEC) with the benefits of ion-exchange chromatography (IEC). Both SEC and IEC can be used for purification of biomolecules. According to various embodiments, SEC can separate molecules on the basis of their hydrodynamic volume, with larger molecules requiring less eluent, for example, a lesser elution volume, than smaller molecules. In SEC, the larger molecules can elute first. SEC can be used in a "spin column" format for biomolecule purification, wherein the column is not required to continually elute but can, for example, elute with a fixed volume, such as the volume in the sample.
  • SEC In a spin column format SEC, larger molecules can be eluted from the column while smaller molecules remain in the column and can later be discarded.
  • SEC can be used for group separation, for example, for the purification of DNA sequencing reactions or the purification of PCR products, wherein the desired product, for example, a sequencing ladder or a PCR product, can flow through the column while undesirable products, for example, primers and ions that are not of interest, remain trapped in the column.
  • SEC can also be used for desalting applications where salts are retained in the column.
  • IEC can differ from SEC, for example, in the order of elution of species from a column.
  • IEC selectivity can be based on, for example, the charge of the analyte. Larger molecules can have a higher charge, and thus a higher affinity for the IEC resin than smaller molecules. Biopolymers, for example, DNA, have a high affinity for IEC resin because the charge of the species increases linearly with the size of the molecule, such that larger molecules can have a higher charge than smaller molecules.
  • Smaller, lesser-charged species for example, salts and nucleotides
  • a larger species such as, for example, PCR products or DNA sequencing ladders
  • EEC and SEC can result in different elution orders, with SEC first eluting larger molecules, and IEC first eluting smaller molecules.
  • SEIE particles can enable high quality separation of biomolecules by combining the effects of SEC and EEC.
  • SEIE particles can use a size-exclusion shell to restrict the ability of large molecules to interact with an ion- exchange core.
  • SEIE particles can combine the high selectivity and binding ability of IEC resins with the size-exclusion benefits of SEC.
  • Small molecules that can penetrate the size- exclusion shell of the SEIE particle can interact with the ion-exchange core and can be retained on the core.
  • Larger, highly charged species can be restricted from interacting with the ion-exchange core by the size-exclusion shell of the SEEE particle. Such larger, highly charged species can remain in solution rather than bind to the ion-exchange core.
  • Eluting SEEE particles can differ from elution of an SEC column in that additional volume in an SEIE column or bed optionally does not elute the bound material because the bound material is held on the ion-exchange core of the SEEE particles, and can be kept from reacting with an eluent to be removed from the column or bed.
  • FIG. 1 and 2 An example of an SEIE particle interaction is shown in Figs. 1 and 2.
  • Figs. 1 and 2 are not drawn to scale, and the relation between objects in the figures, such as the relation between core pore sizes and shell pore sizes, is not to scale, and can in fact be inverse, such that the core pore size is larger than the shell pore size.
  • large molecules such as long single stranded DNA (ssDNA) fragments, and double stranded DNA (dsDNA), are too large to pass through a pore 25 of a size-exclusion shell 20 of a size-exclusion anion- exchange particle 30.
  • ssDNA long single stranded DNA
  • dsDNA double stranded DNA
  • small molecules can slide past or bounce off an exterior surface 21 of the shell 20, and remain in solution rather than ion-exchanging with the anion- exchange particle 30.
  • Small molecules such as deoxynucleotide triphosphates (dNTPs), dye-labeled deoxynucleotide triphosphates, dideoxynucelotide triphosphates (ddNTPs), dye- labeled dideoxynucelotide triphosphates, and small ions, such as chlorine, can pass through the pores 25 of the size-exclusion shell 20 and can undergo ion-exchange with anion- exchange resin 13 at or near the interface 23 of the shell and ion-exchange core 11, or within the pores of ion-exchange core 11.
  • dNTPs deoxynucleotide triphosphates
  • ddNTPs dideoxynucelotide triphosphates
  • small ions such as chlorine
  • the anion-exchange resin 13 for example, a cross-linked, macroporous copolymer of methyl methacrylate and 2- hydroxy-3-memacryloyloxvpropylfrimethyl.immor-ium chloride, can be present on all internal and external surfaces of the solid core material 12. Together, the anion-exchange resin and solid core material or support 12 form the anion-exchange core 11.
  • Counter-anions released from the anion-exchange core 11, such as hydroxide, can react with a counter- cation, for example, hydronium, of a cation-exchanger 35 that can be provided in a mixture with the SEIE particle 30, to produce a neutral molecule such as water.
  • a counter- cation for example, hydronium
  • SEIE particles can be used in a mixture, a mixed bed, or a homogeneous bed of particles. Wherein a homogeneous bed of anionic- or cationic-SEIE particles is used, the counter-ion can be released directly into a sample solution upon ion-exchange. In certain cases, the presence of the counter-ion in the sample solution does not affect further processing or reaction of the sample.
  • the selectivity of an SEIE particle can be determined by the nature of the size-exclusion shell, the charge of the ion-exchange core, and the nature of the counter-ion.
  • a size-exclusion shell can be a cross-linked or polymerized monomer, such as a hydrogel.
  • polymer As used herein, unless otherwise specified, the terms “polymer,” “polymerization,” “polymerize,” “cross-linked product,” “cross- linking,” “cross-link,” and other like terms, are meant to include both polymerization products and methods, and cross-linked products and methods wherein the resultant product has a three-dimensional structure, as opposed to, for example, a linear polymer.
  • polymer also refers to oligomers, homopolymers, and copolymers.
  • the degree of cross- linking of the shell can be varied in order to vary the size of the pores of the shell.
  • the pore size of the shell can be large enough to allow relatively small ions, such as, for example, chloride, nucleotides, or other small molecules, to permeate through the shell.
  • the pore size of the shell can be small enough to prevent any relatively large molecules, such as DNA, from permeating through the shell.
  • the shell can be hydrophilic to reduce passive adsorption or absorption of biomolecules such as, for example, ssDNA fragments.
  • a shell can be a cross-linked product of two or more reactive monomeric units.
  • the monomeric units can be water-soluble monomeric units.
  • water-soluble includes materials with any degree of water solubility from slightly water-soluble to highly water-soluble, and materials that are swellable in water.
  • the monomeric units can be nitrogen-containing, oxygen-containing, or both.
  • the shell can be a homopolymer, a copolymer, a terpolymer, or another polymer.
  • the shell can be the reaction product of an acrylamide, such as polyacrylamide.
  • the shell can be a reaction product of acrylamide and N,N'-methylenebisacrylamide, or acrylamide and 2,2- bis(acrylamido)acetic acid.
  • the shell can be a reaction product of poly(ethylene glycol) (meth)acrylate and poly(ethylene glycol) diacrylate.
  • exemplary water-soluble polymers can include, but are not limited to, poly((meth)acrylamide); poly(N-methyl (methyl)acrylamide); poly(N,N-dimethyl (methyl)acrylamide); poly(N-ethyl (meth)acrylamide); poly(N- «-propyl (meth)acrylamide) poly(N-wo-propyl (meth)acrylamide); poly(N-ethyl-N-methyl (meth)acrylamide) poly(N,N-diethyl (meth)acrylamide); poly(N-vinylformamide); poly(N-vinylacetamide) poly(N-methyl-N-vinylacetamide); poly(vinylalcohol); poly(2-hydroxyethyl
  • the shell can be neutral, anionic, or cationic.
  • the shell can be hydrophilic.
  • the shell can be a cross-linked polymer network of polymers capable of swelling in water, for example, hydrogels. Exemplary hydrogels are described, for example, in U.S. Patent No. 6,380,456 Bl, incorporated herein in its entirety by reference.
  • the shell once formed, can be non- water soluble.
  • the shell can prevent adsorption of ssDNA fragments and/or double-stranded DNA (dsDNA) fragments.
  • polymerization can be initiated thermally, photochemically, ionically, or by any other means known to those skilled in the art of polymer chemistry.
  • the polymerization can be condensation (or step) polymerization, free- radical polymerization, atomic-transfer free-radical polymerization, living free-radical polymerization, or ring-opening polymerization.
  • the shell can be formed with pores of a predetermined size.
  • the various pores of a single SEIE particle can be of the same or varying size.
  • the pores can function as size-exclusion openings for preventing molecules larger than a certain size from passing through the shell to the ion-exchange core that is micro- encapsulated by the shell.
  • the shell can be formed by cross-linking one or more reactive monomer by addition of a cross-linker, for example, N,N'-methylenebisacrylamide or 2,2-bis(acrylamido)acetic acid.
  • the cross-linker or initiator can be added in an amount of from 0.1 mol% to 95 mol% based on the number of moles of reactive monomer units that can cross-link.
  • the cross- linker can be added in an amount of from 0.1 mol% to 70 mol%, from 2.0 mol% to 50 mol%, from 5 mol% to 30 mol%, or from 10 mol% to 20 mol%, based on the number of moles of reactive monomer units that can cross-link.
  • the amount of cross-linker used to form the shell can be at least one factor in determining the size of the pores of the shell, and the size-exclusion ability of the shell.
  • the choice of cross-linker, and/or selection of the reaction conditions can control the amount of cross- linking of the shell.
  • various multifunctional cross-linkers can be used that have varying amounts of functionality.
  • the appropriate amount of a cross-linker to use to form a desired shell pore size can be determined by those of ordinary skill in the art based on the functionality of the cross-linker chosen, the reaction conditions, and other factors as known to those of ordinary skill in the art.
  • the shell pore size can be equal to or smaller than a 10 nt ssDNA.
  • the shell pore size can be equal to or smaller than a 100 nt ssDNA.
  • the shell can be formed by reacting any two of the following that provide cross-linked reaction products: N,N'- methylenebisacrylamide, 2,2-bis(acrylamido)acetic acid, poly(ethylene glycol) (meth)acrylate, poly(ethylene glycol) diacrylate, N,N'-di(meth)acryloylpiperazine, tri(meth)acryloylperhydro-s-triazine.
  • the shell can permit nucleotides, oligonucleotide primers less than 100 nt in size, and buffer salts, to pass through the shell to the ion-exchange core while molecules 100 nt in size or larger are deflected by the shell.
  • the SEIE particles can be used for purification of biological samples, for example, PCR products, to separate larger DNA, for example dsDNA, from ssDNA, free nucleotides, salts, and ions.
  • the shell pore size is larger than 100 nt ssDNA, for example, 300 nt , 800 nt, or 1500 nt
  • the shell permits nucleotides, oligonucleotides, salts and primers less than 300 nt , 800 nt, or 1500 nt, respectively, to pass through.
  • the shell can permit salts and smaller nucleotides to pass through the size- exclusion shell to react with the ion-exchange core.
  • the SEEE particle can be used for purification of biological samples, for example, resulting from a sequencing reaction.
  • Purification of a sequencing reaction sample can remove dye-labeled dideoxynucleotides and salts from the sequencing reaction sample by allowing such components to pass through the shell and react with the ion-exchange core, leaving a purified sample containing an amount of ssDNA relative to the pre-filtered amount, in an amount of 70% or more, 80% or more, 90% or more, or 95% or more.
  • the shell pore size is larger than 10 nt ssDNA, for example, 30 nt , the shell permits nucleotides, oligonucleotides, salts and primers less than 30 nt to pass through.
  • the shell pore size can also be smaller than 10 nt, so long as the pore size still admits a primer having a chain terminator, dye, or other attachment desirous of being separated from a sample, through the shell.
  • the pore size can be 5 nt ssDNA or larger.
  • the particles admitted to or deflected from the shell are not necessarily exactly the "pore size" given. That is, admittance to or exclusion from the pore is based on many factors, including actual pore size (wherein each pore of a shell can have a different size), steric hindrance factors, ionic attractions, polarizations, and the like.
  • a "pore size” thus is a mean measurement, providing a guideline that particles larger than the pore size have a higher chance of not passing through the shell, while smaller particles have as larger chance of passing through the shell.
  • a shell can be formed simultaneously with micro-encapsulation of the ion-exchange core.
  • a shell can be formed by inverse emulsion polymerization of a water-soluble reactive monomer, for example, acrylamide, to form a hydrogel.
  • a water-soluble reactive monomer for example, acrylamide
  • an ion-exchange core 10 can be placed in an aqueous monomer solution in a vessel 40.
  • the ion-exchange core 10 can be a surface- activated ion-exchange core.
  • the aqueous monomer solution can include, for example, one or more monomer, for example, acrylamide or N-vinylpyrrolidone, a cross-linker, for example, 2,2-bis(acrylamido)acetic acid, and/or a free radical initiator, for example, sodium persulfate, potassium persulfate, or an azo compound.
  • the solution can further include one or more of a catalyst, a terminator, a chain-stopper, a chain-transfer agent, a promoter, a buffer, and an accelerator.
  • an oil phase 42 can be added to the vessel 40.
  • the oil phase 42 can include an oil and a surfactant, or an oil including a surfactant.
  • the vessel contents can be subjected to inverse emulsification and polymerization, resulting in the formation of size-exclusion ion-exchange particles 30 having an ion-exchange core 10 micro-encapsulated by a partially cross-linked size-exclusion shell 20 in an aqueous solution 46 in vessel 40.
  • SEIE particles produced by inverse emulsion polymerization can be spherical or nearly spherical in shape, or other shapes depending upon of the shape of the ion-exchange core.
  • a shell can be formed by passing a heated ion-exchange core that is impregnated with an initiator, a catalyst, or both, through a fluidized bed of one or more reactive monomers suitable for forming a shell.
  • the fluidized bed can include, for example, acrylamide and N,N'-methylenebisacrylamide.
  • the monomers and/or polymers in the fluidized bed can be in powder form and can be flowed and/or melted into and onto the ion-exchange core.
  • SEEE particles produced by a fluidized bed reaction can be irregular in shape.
  • a shell can be formed on an ion-exchange core such that the shell has a thickness of from 2% to 300% of the diameter of the ion- exchange core, or from 25% to 200% of the diameter of the ion-exchange core.
  • the thickness of the shell can vary over the surface of the ion-exchange core, or the thickness of the shell can be uniform over the entire surface of the ion-exchange core.
  • the shell can at least partially micro-encapsulate the ion-exchange core.
  • the shell material can at least partially fill one or more pore or surface feature, for example, pores, cracks, crevices, pits, channels, holes, recesses, or grooves, of the ion-exchange core.
  • an ion-exchange core can be coated on all internal and external surfaces with a monomer suitable for forming a shell.
  • the monomer can be reacted with one or more of a second monomer, a catalyst, or an initiator to form a cross-linked size-exclusion polymer on all surfaces of the ion-exchange core, with the outermost surface of the size-exclusion polymer forming the outermost surface of the size-excluding shell.
  • Large molecules cannot contact the ion-exchange core because of the presence of the polymer forming the size- exclusion shell on all surfaces of the ion-exchange core.
  • the ion-exchange core can be an anionic or cationic material.
  • the ion-exchange core can be a polymer, cross-linked polymer, or inorganic material, for example, silica.
  • the ion-exchange core can be a solid core material capable of ion-exchange, or a solid core material treated with an ion-exchange resin.
  • the ion-exchange core can be surface-activated.
  • the ion-exchange core can be non-magnetic, paramagnetic, or magnetic.
  • Exemplary anionic ion-exchange core materials include those listed below.
  • Other ion-exchange materials, including cationic ion-exchange materials, and materials capable of being made to ion-exchange, as known to those skilled in the art of ion- exchange can also be used.
  • Table 1 provides examples of ion-exchange material that can be purchased from a variety of manufacturers. Table 1 lists the composition of the core material, the particle size in microns, the anion exchange capacity in microequivalents per milliliter, the protein binding capacity in milligrams of BSA per milliliter and the ionic form of the material. It will be evident to one skilled in the art that is this only a subset of ion-exchange materials that can be purchased or manufactured for this application. [00051] Table 1
  • the ion-exchange core includes a solid core material capable of ion-exchange
  • the solid core material can be macroporous silica, controlled pore glass (CPG), a macroporous polymer microsphere with internal pores, other porous materials as known to those of ordinary skill in the art of ion-exchange separation, or a combination thereof.
  • the solid core material can have various surface features, including, for example, pores, cracks, crevices, pits, channels, holes, recesses, or grooves.
  • the solid core material can include sodium oxide, silicon dioxide, sodium borate, or a combination thereof.
  • the solid core material can be modified to be capable of ion- exchange, for example, modification to be capable of cation-exchange or anion-exchange. Modification of the solid core material can include treatment of the solid core material to form cationic or anionic substituent groups on the surfaces of the solid core material.
  • surface can include external surfaces and/or internal surfaces. Internal surfaces can be, for example, the surfaces of voids or pores within the solid core material.
  • the solid core material can be modified to include one or more of quatemized functional groups, at least one carboxylic acid group, at least one sulfonic acid group, other cationic or anionic functional groups known to those of ordinary skill in the art of ion- exchange separation, or a combination thereof, on the surface of the solid core material.
  • the solid core material can be microporous, mesoporous, and/or macroporous.
  • the solid core material can have an average pore size of less than or equal to 1000 Angstroms, for example, from 100 Angstroms to 1000 Angstroms, or less than or equal to 100 Angstroms.
  • the average diameter of the solid core material can be from 0.1 ⁇ m to 500 ⁇ m, from 1 ⁇ m to 250 ⁇ m, from 1 ⁇ m to 150 ⁇ m, from 1 ⁇ m to 100 ⁇ m, or from 2 ⁇ m to 20 ⁇ m, for example.
  • the average diameter of the solid core material can be 250 ⁇ m or less, 150 ⁇ m or less, 100 ⁇ m or less, 50 ⁇ m or less, or 20 ⁇ m or less.
  • a solid core material can adsorb an ion- exchange resin onto the external surface, internal surface, or both the external and the internal surface of the solid core material to form the ion-exchange core.
  • the term "resin" can encompass a resin or a gel.
  • the ion-exchange resin can be a cation- exchange resin or an anion-exchange resin.
  • the ion-exchange resin can include one or more quatemized functional groups, one or more non-quarternized amine group, at least one carboxylic acid group, at least one sulfonic acid group, or a combination thereof. Suitable anion-exchange resins and cation-exchange resins would be recognized by those of ordinary skill in the art of ion-exchange in view of the present teachings.
  • the ion-exchange resin can be sequestered into the pores of the solid core material, for example, a macroporous silica particle. Filling at least a portion of the pores of the solid core material and/or coating the external surface of the solid core material with an ion-exchange resin can increase the ion-exchange capacity of the SEIE particle relative to traditional ion-exchange resins.
  • An ion-exchange capacity of an SEIE particle can be improved by increasing a mass of ion-exchange resin, such as quaternary ammonium resin, on the external surfaces and/or on the internal surfaces of the pores of the ion-exchange core.
  • the ion-exchange capacity of an SEIE particle can be improved by appropriate selection of cationic or anionic functional groups on the external surfaces, internal surfaces, or both internal surfaces and external surfaces of the solid core material.
  • the ion-exchange resin can be formed in situ on the solid core material.
  • a first monomer 16, pre-polymer or polymer can be impregnated in the solid core material 12, to include contacting the surfaces of pores 32.
  • the impregnated first monomer 16, pre-polymer, or polymer can be reacted with a second monomer, compound, or pre-polymer, and, optionally, an initiator, to form a cross-linked ion-exchange resin 14 in situ in and on the solid core material 12, including on the internal surfaces of the pores 32.
  • An ion-exchange core 10 results.
  • the ion- exchange resin can be the product of one or more monomer, one or more prepolymer and/or polymer, or a combination thereof, according to various embodiments.
  • the formed ion- exchange core 10 can be micro-encapsulated, for example, by inverse emulsification and polymerization, by a shell 20 having pores 25 to form a size-exclusion ion-exchange particle 30.
  • an anion-exchange core can be formed and micro-encapsulated by a shell.
  • polyethylenimine can be impregnated onto the surface of a solid core material, including onto the internal surfaces of pores of the solid core material.
  • a solid core material of SiO 2 having an average pore size of 1000 Angstroms, a void volume of 0.95cc/g, and a diameter of 5 ⁇ m, can be added to a solution of polyethyleneimine in methanol and incubated for a time sufficient to impregnate the polyethyleneimine into the core and substantially onto all internal and external surfaces of the solid core material.
  • polyethylenimine can be adsorbed on the solid core material due to hydrogen bonding with silanol groups in the solid core material.
  • the adsorbed polyethylenimine can then be reacted with a second compound, such as, for example, 1,3-dibromopropane, in a solvent, for example, dioxane, to form a cross-linked network that functions as an anion-exchanger.
  • a cross-linked network can form a swollen gel when added to water.
  • the anion exchanger can be quarterized by reacting the cross-linked network with an alkyl halide, resulting in a strong anion-exchanger.
  • the resultant anion-exchange core can be micro-encapsulated by a shell of, for example, polyacrylamide, to form a size- exclusion anion-exchange particle.
  • a shell of, for example, polyacrylamide By methods known to those of ordinary skill in the art of ion-exchange separation, other anion-exchange resins or cation-exchange resins can be impregnated or retained on at least a portion of the internal surfaces, on at least a portion of the external surfaces, or on at least a portion of all surfaces of the solid core material of the ion-exchange core.
  • An ion-exchange core can be a pellicular ion-exchange core prepared by surface agglomeration.
  • a large, sulfonated, cation-exchange bead can be coated with a layer, for example, 0.1 um, high-capacity anion exchange particles to form a thin shell of high capacity anion exchange material on the surface of the cation-exchange bead.
  • Methods of forming pellicular ion-exchange core are taught, for example, in J. Weiss, Handbook of Ton Chromatography 1986, and C. Horvath, Pellicular Tr Exchanger ⁇ Rrmrled Stationary Phases in Chromatogra ⁇ r ⁇ y 3 Ann Arbor Science, 1974,
  • the ion-exchange core can be surface- activated to enhance or aid in formation of the shell around the ion-exchange core.
  • Surface activation of the ion-exchange core can include, for example, derivatization of ion- exchange core functional groups by monomers, absorption of polyanions onto the ion- exchange core by ionic interaction with an ion-exchange resin of the ion-exchange core, passive adsorption onto the ion-exchange core of a neutral and water-soluble or at least partially water-soluble oligomer, polymer, or co-polymer, a neutral and organic soluble oligomer, polymer, or co-polymer, a charged initiator through ionic interaction, or a combination thereof.
  • the ion-exchange core can be surface- activated by derivatization of ion-exchange core functional groups with acrylic acid or acryloyl chloride.
  • ion-exchange core functional groups with acrylic acid or acryloyl chloride.
  • an ion-exchange core of Macro-Prep® anion-exchange resin from Bio-Rad can be derivatized.
  • the anion-exchange resin 100 is formed with anion-exchange quarternary ammonium groups attached to the backbone through an epoxy co-monomer linkage. Hydroxyl groups are left on the anion-exchange resin 100 after quarternization, and the hydroxyl groups are subject to further modification.
  • Reacting anion-exchange resin 100 with acryloyl chloride 105 provides surface-activated anion-exchange resin 110 having acryloyl groups useful for grafting the shell polymer onto the anion-exchange core.
  • anion-exchange resin 100 can also be surface-activated by adsorbing negatively charged acrylic acid 115, or its anionic version, by ionic interaction, onto the surfaces of the positively charged anion-exchange resin 100. This surface-activation provides a surface-activated anion-exchange resin 120 which can co-polymerize with a pre-polymer or monomer to form a shell around the anion-exchange core.
  • an ion-exchange core can be surface- activated by absorption of charged or neutral polymers onto the surface of an ion-exchange resin that forms at least part of an ion-exchange core.
  • an anion-exchange resin can be surface-activated by adsorbing a negatively charged polymer, for example, a polyanion.
  • the polyanion can be, for example, poly(meth)acrylic acid; copolymers of (meth)acrylic acid with one or more of (meth)acrylamide, N-methyl (meth)acrylamide, N- ethyl (meth)acrylamide, N-wo-propyl (meth)acrylamide, N-rc-propyl (meth)acrylamide, N,N-dimethyl (meth)acrylamide, N-ethyl-N-methyl (meth)acrylamide, N,N-diethyl (meth)acrylamide, N-vinylpyrrolidone, N-vinylacetamide, N-vinylformamides, N-methyl- N-vinylacetamide, 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (methyl)acrylate, poly(ethyleneglycol) acrylate, poly(ethyleneglycol) methacrylate, vinylmethyl ether, vinyl alcohol precursor, vinyloxazolidone, vinylmethyloxazolidone,
  • the acrylic moiety of the polyanion enables the polyanion to anchor itself onto the surface of the anion-exchange resin by ionic interaction.
  • the polyanion is a (meth)acrylamide moiety or an N,N-dimethyl (meth)acrylamide moiety
  • these moieties enable the partition of the monomer, co-monomers, and their polymerization products, for example, oligomers, onto the surfaces of the core resin.
  • These partitioned monomers, co-monomers, and their polymerization products can become an integral part of the shell during the micro-encapsulation process.
  • a reactive (polymerizable) polyanion 150 can be formed by copolymerizing acrylamide 130, acrylic acid 135, and an NHS ester of acrylic acid 140.
  • the resulting reactive polyanion 150 having negatively charged CO 2 " groups can be anchored onto the surface of an anion-exchange resin of an anion-exchange core 12, wherein the resin has positively charged groups of + NX 3 and/or + NHY (both designated as *) on the surface and/or in the pores of the core 12, where X and Y are independently selected from C n H 2n + ⁇ , and n is an integer greater than or equal to 1, and wherein the resin has negatively charged chloride CF groups (designated as ⁇ ) in the pores of the core.
  • Inverse emulsification forms a water shell, or a water jacket, 200 around the anion exchange core 12 and reactive polyanion 150.
  • the water shell 200 comprises reactive monomer, comonomers, crosslinker, and initiator dissolved therein. Polymerization of the water shell 200 can form a shell 20 around the ion-exchange core 12, resulting in the formation of an SEIE particle 30.
  • the reactive allyl groups or acrylamido groups of polyanion 150 afford grafting of the shell onto the anion-exchange resin of the ion-exchange core 12.
  • an ion-exchange core can be surface- activated by passive adsorption of a neutral, water-soluble or organic soluble polymer, onto the ion-exchange core.
  • the neutral, water-soluble or organic soluble polymer can be, for example, poly(N-vinylpyrrolidone) or copolymers thereof; poly(vinyl acetate-co-vinyl alcohol); polyacrylamide or copolymers thereof; poly(N,N-dimethyl acrylamide) or copolymers thereof; poly(N-vinylamides) or copolymers thereof; poly(ethyleneoxide-co- propyleneoxide); amphiphilic diblock and amphiphilic block copolymers, for example, poly(styrene-b-2-hydroxyethyl (meth)acrylate), poly(styrene-b-(methyl)acrylamide), poly(styrene-b-N,N-dimethyl (meth)acrylamide).
  • an ion-exchange core can be surface- activated by ionic-interaction with a charged initiator, for example, a photo-initiator or a thermal initiator containing one or more negatively charged functional group.
  • a charged initiator for example, a photo-initiator or a thermal initiator containing one or more negatively charged functional group.
  • an initiator 155 can be provided in the form of 4,4'-azobis(4- cyanopentanoic acid) that contains two carboxylic acid groups per molecule.
  • the initiator 155 with ionic group CO 2 " (designated as ⁇ ) can be adsorbed onto the surface of an anion- exchange core 12 having ionic groups of NME 3 (designated as *) and CI " (designated as ⁇ ), to form a surface-activated ion-exchange core 160.
  • the surface-activated ion- exchange core 160 can be subjected to inverse emulsification to form a water shell, or a water jacket, 200 around the surface-activated ion-exchange core 160.
  • Water shell 200 comprises reactive monomer, comonomers, and cross-linker dissolved therein.
  • Water shell 200 and core 160 form structure 170, which can be thermally polymerized to form an SEIE particle 190 having a shell 20.
  • initiator 155 on the surface of ion-exchange core 160 can undergo thermal decomposition in an aqueous or a non-aqueous monomer solution that includes a monomer, for example, N,N-dimethylacrylamide, and a cross-linker, for example, 2,2- bisacrylamidoacetic acid, to form a structure 180 with surface-bonded free radicals (designated as o) that initiates free-radical polymerization to form an SEIE particle 190 having a shell 20.
  • a monomer for example, N,N-dimethylacrylamide
  • a cross-linker for example, 2,2- bisacrylamidoacetic acid
  • Purification of a sample within the ion-exchange core can be by ion-exchange.
  • Each charge equivalent that can be absorbed on the ion-exchange core can release an equivalent charge into an appropriate solution.
  • this displacement of counter-ions from the ion-exchange core can release a large number of counter-ions into a sample solution.
  • the sample solution can increase in chloride ion concentration.
  • the selectivity of the ion-exchange core can be greater for the ion to be removed from the sample solution than for the counter-ion of the ion-exchange core.
  • the ion- exchange core is an anion-exchange core in chloride form, wherein the counter-ion is chloride
  • the ion to be removed from the sample solution can have a greater affinity for the anion-exchange core than the chloride counter-ion, in order to replace the chloride ion in the resin and release the chloride ion into the sample solution.
  • the counter-ion is chloride
  • some ions, such as hydroxide or phosphate can be retained by an anion-exchange core in low quantities because these anions have an affinity for the anion-exchange core similar to that of chloride ions.
  • an anion-exchange core can have a hydroxide counter-ion, such that hydroxide can be released when an ion with affinity for the anion-exchange core is retained on the anion-exchange core.
  • a hydroxide counter- ion is used, chloride ions can be weakly attracted to the anion-exchange core because chloride and hydroxide have a similar affinity for charge.
  • a cation-exchanger or size- exclusion cation-exchange particle in protonated form can be used with a size-exclusion anion-exchange particle having a hydroxide counter-ion to drive the reaction of the sample solution forward, and to improve retention of low affinity ions, such as chloride ions.
  • an ion-exchange core can contain a lower mobility counter-ion, for example, octane sulfonate.
  • An ion-exchange core can contain a volatile counter-ion, for example, acetate for an anion-exchange material, or ammonium for a cation-exchange material.
  • the volatile counter-ion such as acetate or ammonium, can later be removed from a sample solution.
  • the counter-ion for an anion-exchange core can be, for example, a halide or hydroxide.
  • the counter-ion for a cation-exchange core can be, for example, hydrogen.
  • a mixed bed including an SEIE particle and an ion-exchange resin can be desirable in order to drive the removal of ions, such as salt ions and counter-ions released from the SEIE particle, from the sample solution.
  • ions such as salt ions and counter-ions released from the SEIE particle
  • a size-exclusion anion-exchange (SEAE) particle can be combined with a bare cation-exchange resin such that the counter-ions released from the SEAE particle react with counter-ions released from the cation-exchange resin to form neutral compounds, such as water, or volatile substances which can be driven from the mixed bed during the reaction. Whether neutral or volatile, the generation of such inert or separable products drives forward the retention of ions from a sample solution by the SEAE particles.
  • SEAE size-exclusion anion-exchange
  • a mixed bed of a size-exclusion cation-exchange (SECE) particles and a bare anion- exchange resin can be used.
  • SEAE particles and SECE particles can form a mixed bed.
  • a mixed bed ion-exchanger can include an SEAE particle having an anionic ion-exchange core in hydroxide form.
  • a mixed bed can be used for bulk phase desalting of a sample solution.
  • An SEAE particle can be prepared in the hydroxide form and can be mixed with an SECE particle or cation-exchange resin prepared in the hydrogen form, to form a mixed bed.
  • An anion in a sample solution can displace a hydroxide ion from the SEAE particle to become bound to the ion-exchange core thereof.
  • the hydroxide ion can cause the sample solution to become basic.
  • a mixed bed the hydroxide ion released from the SEAE particle and the hydronium ion released from the cation-exchange resin or SECE particle can react irreversibly to form water, continually removing hydroxide and hydronium from the sample solution, and maintaining a low ionic strength of the sample solution.
  • the mixed bed can drive the removal of lower affinity anions such as, for example, chloride, from solution.
  • the mixed bed can maintain a stable pH of the sample solution.
  • the mixed bed can drive adsorption of anions and cations from the sample solution onto the respective SEAE and SECE particles.
  • a mixed bed can desalt a sample solution.
  • a SEAE particle with an ion-exchange core in hydroxide form can be mixed with a stoichiometrically equal amount of cation-exchange resin or SECE particles in the hydrogen form.
  • a high capacity de-salting/cleaning agent can be formed by a mixture of SEAE particles, for example, in hydroxide form, or anion- exchange resin, for example, in hydroxide form, and a protonated conventional cation- exchange resin or protonated SECE particles.
  • the volume of the de-salting/cleaning agent is a function of the ionic capacity of the resin and can be less than the volume of a sample solution, to effect de-salting/cleaning of the sample solution.
  • a mixed-bed can include SEAE particles and SECE particles, for example, in a stoichiometrically equivalent amount, SEAE particles and a cation-exchange resin, for example, in a stoichiometrically equivalent amount, or SECE particles and an anion-exchange resin, for example, in a stoichiometrically equivalent amount.
  • the amount of material capable of anion-exchange for example, SEAE particles or an anion-exchange resin
  • a mixed-bed can include SEAE particles and SECE particles, for example, not in a stoichiometrically equivalent amount, SEAE particles and a cation-exchange resin, for example, not in a stoichiometrically equivalent amount, or SECE particles and an anion-exchange resin, for example, not in a stoichiometrically equivalent amount.
  • SEAE particles and SECE particles for example, not in a stoichiometrically equivalent amount
  • SECE particles and an anion-exchange resin for example, not in a stoichiometrically equivalent amount.
  • An exemplary PCR product solution can contain amplified target sequences (amplicons), buffer salts, metal ions, enzymes (e.g.
  • PCR products can be analyzed, or used in subsequent enzymatic reactions that can be sensitive to at least some of the artifacts found in a sample solution containing the PCR products.
  • free nucleotides and oligonucleotide primers can interfere with downstream enzymatic reactions.
  • a size-exclusion limit of an SEIE particle can be, for example, a 100 nt ssDNA.
  • An SEIE particle can trap and remove, for example, nucleotides, oligonucleotide primers, and buffer salts, that are less than 100 nt or an equivalent size.
  • the resulting solution can contain purified PCR products in a desalted environment, and can be used in downstream reactions and analyses.
  • PCR purification can be directed toward separating larger double stranded DNA (dsDNA) from smaller ssDNA, and dsDNA (e.g. primer-dimer, an unwanted side reaction product which is a dsDNA), free nucleotides, and salts.
  • PCR product purification using SEIE particles can isolate, for example, a 250-600 bp amplicon and can remove 44 nt primers, nucleotides, or both.
  • DNA sequencing reaction solutions can contain, for example, buffer salts, metal ions, polymerase, nucleotides, oligonucleotide primers, and other components.
  • SEIE particles for the purification of sequencing reaction solutions can differ from those used in the purification of PCR reaction solutions.
  • sequencing reaction products can contain residual, unincorporated dye-labeled dideoxynucleotides (terminators) that can be removed prior to electrophoretic analysis and DNA sequencing or basecalling. Failure to remove such compounds can result in "blobs" that can cause errors in DNA sequencing or basecalling.
  • Capillary sequencers can use electrokinetic injection as a means to introduce DNA sequencing reaction samples. The presence of salts in the samples can effect the introduction of the sample into the capillary, where a reduced salt concentration can be required for injection into the capillary.
  • DNA sequencing reaction samples can be desalted by purification with SEIE particles.
  • a sample solution purified with SEIE particles can have a salt concentration of less than or equal to 100 ⁇ M.
  • a sample solution purified with SEIE particles can have a salt concentration of less than or equal to 50 ⁇ M.
  • a sample solution purified by SEIE particles can be suitable for electrokinetic capillary injection.
  • the SEIE particle can have a size-exclusion limit of, for example, less than 10 nt ssDNA, and can be able to remove small ions such as salts and dye-labeled nucleotides from a sample solution while leaving ssDNA free in solution.
  • Sequencing reaction purification using SEIE particles can be used to separate ssDNA, for example, having a size of from 10 nt to 1500 nt or larger in size, from smaller components such as, for example, dye-labeled nucleotides and salts.
  • DNA purification can occur in a bulk mode using SEIE particles.
  • a well-formed chromatographic bed of SEIE particles is not necessarily required.
  • a device including SEIE particles as described herein can be a microfluidic device having one or more pathway, wherein at least a portion of at least one pathway contains the SEIE particles.
  • the device can have an inlet and an outlet in fluid communication with the SEIE particles.
  • the particles can be present in, for example, a column.
  • a column can be in a horizontal or vertical orientation, or in any position between a horizontal and a vertical orientation.
  • the column can include a cavity, chamber, reservoir, well, reaction region, bed, recess, or other receptacle suitable for containing or retaining SEIE particles and a sample solution.
  • the column can contain one or more SEIE particles.
  • the outlet of the device can be in fluid communication with a receptacle, such as a purified sample well, a tube, a glass plate, or another means of collecting a purified sample.
  • a method using such a device is provided for purifying a sample solution.
  • the device can include size-exclusion ion-exchange particles, such as size-exclusion anion-exchange particles, size-exclusion cation-exchange particles, or a combination thereof.
  • the method can include adding the particles to the column of the device.
  • a bare cation-exchange resin, anion-exchange resin, or both, can optionally be added to the column of the device.
  • a sample for example, a PCR purification product solution or a sequencing reaction product solution, can be placed in or introduced to the inlet of the device.
  • the sample can travel from the inlet through the column containing SEIE particles and optional additional ion-exchange resin.
  • the sample can be subjected to a combination of size-exclusion separation and ion-exchange resulting in a filtration and/or purification of the sample.
  • the filtered and/or purified solution can be eluted or removed from the column through the outlet, and can be directed to a receptacle for analysis and/or further processing.
  • the sample can be moved through the column by centripetal force.
  • purification of a sample using SEIE particles can be achieved using a volume of SEIE particles that is sufficient to provide adequate ion-exchange capacity, such as, ion-exchange of at least 80%, at least 90%, or at least 95% of the sample.
  • the purification can occur in ten minutes or less, five minutes or less, or two minutes or less.
  • the purification can include contacting a sample with the SEIE particles for a period of time sufficient for the SEIE particles to ion-exchange with the sample, and removing the purified sample from the SEIE particles.
  • separating the purified sample from the particles can comprise removing the purified sample from the particles, removing the particles from the purified sample, and/or sampling the purified sample from the mixture of particles and purified sample.
  • An example of sampling the purified sample from the mixture of particles and purified sample comprises analyzing the product in a tube by dipping a capillary directly into the tube and injecting into a sequencer.
  • a solution was prepared from 2.4957 g (35.11 mmol) acrylamide (99+% pure, Aldrich Chemical, St. Louis, Missouri) and 0.7021 g (4.55 mmol) of N,N'- methylenebisacrylamide (99+ pure, Aldrich Chemical) in 11.9391 g of water (Milli-Q Water System, Millipore of Billerica, Massachusetts). To the solution was added, with swirling, a suspension of 0.7158 g of MACRO-PREP HQ macroporous anion-exchange core (Bio-Rad of Hercules, California) in 2.0075 g of water (Milli-Q Water System, Millipore).
  • the suspension of MACRO-PREP HQ was prepared 30 minutes ahead of time with occasional swirling prior to use.
  • the mixture of monomer solution and the MACROPREP suspension was poured into a solution of 1.0072 g of SPAN-80 (sorbitan monooleate, Fluka of Buchs, Switzerland) in 20.10 g of PETROLEUM SPECIAL (bp 180- 220 °C, Fluka) and stirred at 3600 rpm.
  • Emulsification was carried out at ambient temperature for 2.5 minutes.
  • the emulsion was added to a 24/40 three-necked round bottom flask, equipped with a water-cooled condenser, a bleeding tube for purging, and a mechanical stirrer with a 1" stainless steel 3-blade propeller.
  • the emulsion was purged by ultra-pure helium at a flow rate of 100 mL/min for 30 minutes.
  • 0.5 mL (0.044 mmol) of a solution of 0.4507 g of ammonium persulfate (99.99+% pure, Aldrich Chemical) in 22.1652 g of water (Milli-Q Water System, Millipore) was added.
  • the reaction flask was lowered into an oil bath at 45 ⁇ 1°C and 50 ⁇ L (0.33 mmol) N,N,N'N'- tetran ethylenethylene-diamine was added to the reaction flask.
  • the SEAE particles were converted to the hydroxide form by repeated washing with IM NH 4 OH (Suprapure grade, EMD of Gibbstown, New Jersey).
  • the volume of acid or base required to convert a given quantity of resin from one form to another can be calculated knowing the concentration of the acid or base and the ionic capacity of the resin.
  • the resin is converted with a 10X excess of the needed acid or base.
  • lOO ⁇ L of particles were vortexed with 800 ⁇ L of IM NH 4 OH, spun down in a microcentrifuge at lOOOx g, and the supernatant was pipetted off. This process was repeated 10 times.
  • the particles were transferred to a spin column and washed 3 times with lOO ⁇ L aliquots of IM NH 4 OH, although this step is optional.
  • the resin bed was washed repeatedly with deionized (DI) water until the effluent was pH neutral (approx. 10 washes with 500 ⁇ L aliquots of DI water).
  • DI deionized
  • SECE particles were prepared for a mixed bed by a similar process.
  • the same process described for converting the SEAE particle to hydroxide form was used to convert the SECE particle to proton form, except washing was performed with IM HCl (Reagent Grade, J.T. Baker) rather than NH OH. The HCl washes were followed by water washes until the effluent was pH neutral.
  • IM HCl Reagent Grade, J.T. Baker
  • the SEAE particles and the SECE particles were semi-dried by spinning 1 minute at lOOOx g.
  • the SEAE particles and the SECE particles were each slurried with 500 ⁇ L DI water.
  • the particles were mixed together at a stoichiometric ratio based on the ionic capacity of the anion and cation exchange beads, respectively, and vortexed to form a mixed bed slurry.
  • the mixed bed was washed twice with sheared salmon sperm DNA (Eppendorf AG of Hamburg, Germany) prepared at a concentration of lmg/mL in DI water. A volume of sheared salmon sperm DNA roughly equal to the volume of the resin bed was used for each wash.
  • the bed of beads was washed 3X with lOOO ⁇ L aliquots of DI water.
  • the slurry was semi-dried by spinning 1 minute at 1 OOOx g and stored at 4°C. Note that, as described, the mixed bed is washed with salmon sperm DNA before use. However, washing of the constituent beads prior to mixing is equally effective. SEAE and SECE resins when used alone (i.e., not in a mixed bed), can also benefit from washing with salmon sperm DNA.
  • PCR PTTRTFTCATTON when used alone (i.e., not in a mixed bed), can also benefit from washing with salmon sperm DNA.
  • PCR purification a sample was prepared containing 102 ⁇ L PCR master mix, 4 ⁇ L FAM-labeled forward primer (20 pmol/ ⁇ L), 4 ⁇ L reverse primer (20 pmol/ ⁇ L), 20 ⁇ L hgDNA, CEPH 1347-02 (50 ⁇ g/ ⁇ L), and 70 ⁇ L deionized water (DI).
  • This master solution was aliquoted into wells in a thermal cycler plate at a volume of 20 ⁇ L/well. The mixtures were heated at 95°C for 5 minutes, followed by 40 cycles of heating, wherein each cycle included heating at 95°C for 30 seconds, then at 60°C for 120 seconds.
  • the mixture was prepared as a settled bed by letting the beads settle and then removing any water above the bed. This settled bed was vortexed and a 1 ⁇ L aliquot was transferred to 50 ⁇ L MicroAmp tube (Applied Biosystems). 1.0 ⁇ L of the previously prepared sequencing reaction was added to the beads and pipet mixed for 15 seconds. The tube was transferred to a vortexer and vortexed for 1 minute. 6 ⁇ L of DI water was added to the tube, pipet-mixed and centrifuged on a bench centrifuge at 500Xg for 30 seconds. The supernatant was removed with a pipet and run on an ABI3100 DNA sequencer. Because the sample is so highly desalted, the injection voltage and time on the sequencer were reduced by a combined factor of 4 so that the data did not go offscale. EXPERIMENTAL RESULTS.
  • peaks from 5000- 7000 scans, labeled 50 are from the FAM-labeled 38 nt primer, while the peak at 23,000 scans, labeled 60, is the FAM-labeled PCR product.
  • Figs. 10a and 10b DNA sequencing of a PCR product purified using SEIE particles is shown in Figs. 10a and 10b.
  • Fig. 10a shows a graphical representation of a detected sequence of an unpurified PCR product. The graph contains much noise and multiple sequences. Several miscalls and ambiguities are visible, and the overall quality is low.
  • Fig. 10b shows a graphical representation of a detected sequence of the same PCR product but purified by contacting the PCR product with the SEIE resin for 10 minutes before sequencing. The sequence of Fig. 10b is clean and readable, unlike the sequence in Fig. 10a.
  • Figs, l la-d show the application of SEIE to DNA sequencing reaction product purification.
  • the graph showing the untreated DNA sequencing reaction product sequence (Fig. 11a) has large artifacts ("blobs") that obscure the sequence data.
  • Fig. l ib shows the result of treatment of a DNA sequencing reaction using a standard CentriSep column.
  • the data of Fig. 1 lb is clearer than that of Fig. 11a.
  • Figs. l ie and 1 Id show the result of treating a DNA sequencing reaction product with the mixed bed SEIE particles for three minutes before sequencing.
  • Figs. 12 and 13 demonstrate the increase in size between an ion-exchange core and a size-exclusion ion-exchange particle.
  • Fig 12 demonstrates the difference in size between a MACRO-PREP HQ anion exchange resin (25 ⁇ m radius) and an SEIE particle made with the resin.
  • Fig. 13 demonstrates the difference in size between a MACROPREP 25Q anion exchange resin (average radius 12.5 ⁇ m) and an SEIE particle made with the resin according to an embodiment (average radius 19 ⁇ m).
  • Figs. 12 and 13 demonstrate that the SEIE particle has a larger size with respect to the ion-exchange core.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Devices For Use In Laboratory Experiments (AREA)

Abstract

L'invention concern une particule d'échange ionique à exclusion de dimension, et un dispositif dans lequel est utilisée cette particule, ladite particule comprenant un noyau d'échange ionique micro-encapsulé dans une enveloppe, l'enveloppe contenant un produit de polymérisation d'un monomère réactif. L'enveloppe peut être un polymère au moins partiellement réticulé. L'enveloppe peut exclure des molécules d'une dimension égale ou supérieure à une molécule d'ADNss 10 nt ou des molécules d'une dimension égale ou supérieure à une molécule d'ADNss 100 nt, par exemple, et le noyau peut faciliter l'échange ionique. L'invention concerne également des procédés de fabrication de particules d'échange ionique à exclusion de dimension, ainsi que des procédés de purification à l'aide des particules.
EP03771853A 2002-07-26 2003-07-25 Particule d'echange ionique a exclusion de dimension Withdrawn EP1525052A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US413935 1982-09-01
US39885202P 2002-07-26 2002-07-26
US398852P 2002-07-26
US414179 2003-04-14
US10/414,179 US20040018559A1 (en) 2002-07-26 2003-04-14 Size-exclusion ion-exchange particles
US10/413,797 US20040016702A1 (en) 2002-07-26 2003-04-14 Device and method for purification of nucleic acids
US10/413,935 US6833238B2 (en) 2002-01-04 2003-04-14 Petal-array support for use with microplates
US413797 2003-04-14
PCT/US2003/023337 WO2004011141A1 (fr) 2002-07-26 2003-07-25 Particule d'echange ionique a exclusion de dimension

Publications (1)

Publication Number Publication Date
EP1525052A1 true EP1525052A1 (fr) 2005-04-27

Family

ID=31192375

Family Applications (3)

Application Number Title Priority Date Filing Date
EP03771827A Withdrawn EP1525299A2 (fr) 2002-07-26 2003-07-25 Support de reseau de petales pour microplaques
EP03771854A Withdrawn EP1525053A1 (fr) 2002-07-26 2003-07-25 Dispositif et procede de purification d'acides nucleiques
EP03771853A Withdrawn EP1525052A1 (fr) 2002-07-26 2003-07-25 Particule d'echange ionique a exclusion de dimension

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP03771827A Withdrawn EP1525299A2 (fr) 2002-07-26 2003-07-25 Support de reseau de petales pour microplaques
EP03771854A Withdrawn EP1525053A1 (fr) 2002-07-26 2003-07-25 Dispositif et procede de purification d'acides nucleiques

Country Status (4)

Country Link
EP (3) EP1525299A2 (fr)
JP (1) JP2005533646A (fr)
AU (3) AU2003254174A1 (fr)
WO (3) WO2004011592A2 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627159B1 (en) 2000-06-28 2003-09-30 3M Innovative Properties Company Centrifugal filling of sample processing devices
US7192560B2 (en) 2001-12-20 2007-03-20 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using anion exchange
US7347976B2 (en) 2001-12-20 2008-03-25 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix
US7981600B2 (en) 2003-04-17 2011-07-19 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using an anion exchange material that includes a polyoxyalkylene
US7322254B2 (en) 2003-12-12 2008-01-29 3M Innovative Properties Company Variable valve apparatus and methods
US7939249B2 (en) 2003-12-24 2011-05-10 3M Innovative Properties Company Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
US7727710B2 (en) 2003-12-24 2010-06-01 3M Innovative Properties Company Materials, methods, and kits for reducing nonspecific binding of molecules to a surface
EP1715953A1 (fr) * 2004-02-18 2006-11-02 Applera Corporation Particules echangeuse d'ions d'exclusion enduites de polyelectrolytes
SE0400490D0 (sv) * 2004-02-26 2004-02-26 Amersham Biosciences Ab Plasmid purification
JP2008536478A (ja) * 2005-02-15 2008-09-11 アプレラ コーポレイション 高分子電解質被覆イオン交換粒子
WO2006089029A2 (fr) 2005-02-15 2006-08-24 Applera Corporation Particules d'echange ionique revetues de polyelectrolytes
US7378260B2 (en) * 2005-04-01 2008-05-27 Applera Corporation Products and methods for reducing dye artifacts
US7763210B2 (en) 2005-07-05 2010-07-27 3M Innovative Properties Company Compliant microfluidic sample processing disks
US7754474B2 (en) 2005-07-05 2010-07-13 3M Innovative Properties Company Sample processing device compression systems and methods
US7323660B2 (en) 2005-07-05 2008-01-29 3M Innovative Properties Company Modular sample processing apparatus kits and modules
US7935518B2 (en) * 2006-09-27 2011-05-03 Alessandra Luchini Smart hydrogel particles for biomarker harvesting
DE102007005655A1 (de) 2007-01-31 2008-08-07 Qiagen Gmbh Vorrichtung und Verfahren zur Aufreinigung von Nukleinsäuren
WO2010027696A1 (fr) * 2008-08-25 2010-03-11 Ge Healthcare Bio-Sciences Corp. Procédé simple de dépôt et d'élution pour la purification d'adn génomique
US8834792B2 (en) 2009-11-13 2014-09-16 3M Innovative Properties Company Systems for processing sample processing devices
US9278297B2 (en) 2010-07-09 2016-03-08 Ge Healthcare Bio-Sciences Ab Method for ion-exchange chromatography and media used thereof
WO2012062753A1 (fr) 2010-11-09 2012-05-18 Qiagen Gmbh Procédé et dispositif pour l'isolement et la purification d'acides nucléiques double brin
BR112013027990B1 (pt) 2011-05-18 2020-11-03 Diasorin S.P.A. estrutura de válvulas em um dispositivo de processamento de amostras e método para funcionamento de válvulas em um dispositivo de processamento de amostras
US9168523B2 (en) 2011-05-18 2015-10-27 3M Innovative Properties Company Systems and methods for detecting the presence of a selected volume of material in a sample processing device
EP2709761B1 (fr) 2011-05-18 2019-08-14 DiaSorin S.p.A. Dispositif et methode de dosage volumetrique sur un dispositif de traitement d' échantillon
US20120291869A1 (en) * 2011-05-20 2012-11-22 Dober Chemical Corporation Systems and Methods for Releasing Additive Compositions
US20130004586A1 (en) * 2011-06-24 2013-01-03 Vachon David J Biologically Efficacious Compositions, Articles of Manufacture and Processes for Producing and/or Using Same
US8822554B2 (en) * 2011-10-04 2014-09-02 Purolite Corporation Aminated ion exchange resins and production methods thereof
JP6363593B2 (ja) * 2012-05-31 2018-07-25 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 負に帯電した粒子を用いたクロマトグラフィによるポリヌクレオチドの精製
GB201214193D0 (en) * 2012-08-08 2012-09-19 Ge Healthcare Uk Ltd Polymerase chain reaction method for amplifying nucleic acid
CN108384780B (zh) * 2018-02-11 2023-12-29 中国农业科学院烟草研究所 一种批量快速提取dna的方法及提取装置
JP7194129B2 (ja) * 2020-01-16 2022-12-21 株式会社豊田中央研究所 冷却液
NL2025044B1 (en) 2020-03-04 2021-10-14 Stichting Wetsus European Centre Of Excellence For Sustainable Water Tech Electrochemical device, system and method for electrochemically recovery and/or regeneration of carbon dioxide from a stream
JP7480070B2 (ja) 2021-01-15 2024-05-09 株式会社豊田中央研究所 冷却液

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
JPS57140644A (en) * 1980-12-15 1982-08-31 Asahi Chem Ind Co Ltd Molded product of composite adsorbent
AU642444B2 (en) * 1989-11-30 1993-10-21 Mochida Pharmaceutical Co., Ltd. Reaction vessel
CA2063855C (fr) * 1991-04-03 1997-08-26 Will Bloch Precision et exactitude de la separation d'acides nucleiques par echange d'anions
SE9700769D0 (sv) * 1997-03-04 1997-03-04 Pharmacia Biotech Ab Matriser för separation och separation som utnyttjar matriserna
EP1177043A2 (fr) * 1999-04-29 2002-02-06 Genome Therapeutics Corporation Dispositif permettant de traiter rapidement un echantillon d'adn par manipulation de liquide, thermocyclage et purification
EP1214149A2 (fr) * 1999-09-21 2002-06-19 Genome Therapeutics Corp. Dispositif de traitement rapide d'echantillons d'adn a manipulation des liquides, thermocyclage, et purification integres
AU1622501A (en) * 1999-11-23 2001-06-04 Porex Corporation Immobilized ion exchange materials and processes for making the same
SE9904272D0 (sv) * 1999-11-25 1999-11-25 Amersham Pharm Biotech Ab A method for selective removal of a substance from samples containing compounds having nucleic acid structure
US6284117B1 (en) * 1999-12-22 2001-09-04 Nanogen, Inc. Apparatus and method for removing small molecules and ions from low volume biological samples
US6504021B2 (en) * 2000-07-05 2003-01-07 Edge Biosystems, Inc. Ion exchange method for DNA purification
WO2002050260A2 (fr) * 2000-12-20 2002-06-27 Altana Pharma Ag Procede de production et de purification de proteines et de production de reseaux de proteines
US20020168643A1 (en) * 2001-05-08 2002-11-14 Wierzbowski Jamey M. Devices and methods for simultaneous separation and purification of molecular samples
KR100425536B1 (ko) * 2001-07-16 2004-03-30 학교법인 포항공과대학교 유체 마이크로칩용 브레드보드
US20030098271A1 (en) * 2001-11-26 2003-05-29 Ralph Somack Capsule and tray systems for combined sample collection, archiving, purification, and PCR
US7192560B2 (en) * 2001-12-20 2007-03-20 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using anion exchange

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004011141A1 *

Also Published As

Publication number Publication date
JP2005533646A (ja) 2005-11-10
AU2003254175A1 (en) 2004-02-16
AU2003256787A8 (en) 2004-02-16
AU2003254174A1 (en) 2004-02-16
AU2003256787A1 (en) 2004-02-16
WO2004011592A3 (fr) 2004-04-22
WO2004011592A2 (fr) 2004-02-05
EP1525299A2 (fr) 2005-04-27
WO2004011142A1 (fr) 2004-02-05
WO2004011141A1 (fr) 2004-02-05
EP1525053A1 (fr) 2005-04-27

Similar Documents

Publication Publication Date Title
US20040018559A1 (en) Size-exclusion ion-exchange particles
EP1525052A1 (fr) Particule d'echange ionique a exclusion de dimension
US20140235846A1 (en) Polyelectrolyte-Coated Ion-Exchange Particles
US6833238B2 (en) Petal-array support for use with microplates
US20140287416A1 (en) Polyelectrolyte-coated size-exclusion ion-exchange particles
AU778045B2 (en) Process for making fluorinated polymer adsorbent particles
EP2277987A2 (fr) Particules échangeuses d'ions revétues de polyelectrolytes
WO2005058453A1 (fr) Procede de concentration et de purification de composes biologiques
EP1226870A1 (fr) Echangeur d'anions, procédé pour sa fabrication, et son utilisation
US20050196856A1 (en) Polyelectrolyte-coated size-exclusion ion-exchange particles
EP1519984B1 (fr) Sorbant polymère fonctionnalisé et procédé
US5986085A (en) Matched ion polynucleotide chromatography (MIPC) process for separation of polynucleotide fragments
EP1436056A2 (fr) Gel macroporeux, sa preparation et son utilisation
US6746608B2 (en) Use of adsorbent polymer particles in DNA separation
US6177559B1 (en) Process for separation of polynucleotide fragments
EP1339876A2 (fr) Purification de reactions de sequen age d'adn au moyen de particules magnetiques de silice
US20050271553A1 (en) Petal-array support for use with microplates
JP4268730B2 (ja) 液体クロマトグラフィー用充填剤の製造方法
EP1848793B1 (fr) Particules d'echange ionique revetues de polyelectrolytes
JP2008536478A (ja) 高分子電解質被覆イオン交換粒子
JPH03179258A (ja) 液体クロマトグラフィー用充填剤の製造方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20081208

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LIFE TECHNOLOGIES CORPORATION

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LIFE TECHNOLOGIES CORPORATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121020